As National Advertising Division referrals to the Federal Trade Commission go, Pursuit of Research’s claims that its dietary supplement treats symptoms of apraxia, autism and epilepsy in children could look familiar and get a quick response at the agency.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?